Clinical trial
Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
NCT00475319 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Late Phase 2 Study of OPC-12759 Ophthalmic Suspension
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- June 30, 2008
- Enrollment
- 308 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.